Abstract
The number of the adult patients with congenital heart diseases (ACHD) continues to grow owing to improvement of surgical results and medical management. Corrective surgery for complex CHD does not always mean complete cure. It is not rare that the patients will visit the cardiology institutes because of secondary lesions due to residua or sequela in adults. Some patients with CHD remain unrepairable with different degree of heart failure and pulmonary arterial hypertension. Association of arrhythmias is common in ACHD patients and sometimes critical. We experienced 265 surgical procedures for ACHD patients at our center between 1999 and 2015. Of these procedures, palliative surgery was performed in 3%, palliation to corrective surgery in 6%, primary repair in 57%, and redo surgery in 34%. Hospital mortality within 30 days in this period was 1.1%. Surgery for ACHD patients is safe, beneficial and low-risk treatment; however, tailored procedures for the individual patient are essential to obtain the optimal quality. A comprehensive multidisciplinary approach is required to fulfill this goal.
Similar content being viewed by others
References
Srinathan SK, Bonser RS, Thorne SA, et al. Changing practice of cardiac surgery in adult patients with congenital heart disease. Heart. 2004;91:207–12.
Niwa K, Akagi T, Ichikawa H, et al. Guidelines for management of congenital heart disease in adults (2011 revised edition). JCS. 2011; 1–135.
Shina Y, Toyoda T, Kawasoe Y, et al. Prevalence of adult patients with congenital heart disease in Japan. Int J Cardiol. 2011;146:13–6.
Walsh EP, Cecchin F. Arrhythmias in adult patients with congenital heart disease. Circulation. 2007;115:534–45.
Ochiai R, Yao A, Kinugawa K, et al. Status and future needs of regional adult congenital heart disease centers in Japan. Circ J. 2011;75:2220–7.
Filippov AA, Del Nido PJ, Vasilyev NV. Management of systemic right ventricular failure in patients with congenitally corrected transposition of the great arteries. Circulation. 2016;134(17):1293 – 302.
Perloff JK. Surgical closure of atrial septal defect in adults. N Engl J Med. 1995;333:513–4.
Giamberti A, Chessa M, Foresti S, et al. Combined atrial septal defect surgical closure and irrigated radiofrequency ablation in adult patients. Ann Thorac Surg. 2006;82:1327–31.
Nitta T, Sakamoto S. Miyagi Y, et al. Reentrant and focal activations during atrial fibrillation in patients with atrial septal defect. Ann Thorac Surg. 2013;96(4):1266–72.
Wi J, Choi JY, Shim JM, Uhm JS, et al. Fate of preoperative atrial fibrillation after correction of atrial septal defect. Circ J. 2013;77(1):109 – 15.
Galie N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, pracebo-controlled study. Circulation. 2006;114:48–54.
Singh TP, Rohit M, Grover A, et al. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Am Heart J. 2006;151(4):851 e1–5.
Fernandes SM, Newburger JW, Lang P, et al. Usefulness of epoprostenol therapy in the severity ill adolescent/adult with Eisenmenger physiology. Am J Cardiol. 2003;91:632–5.
Galie N, Palazzini M, Manes A. Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. Eur Heart J. 2010;31(17):2080–6.
Baumgartner H, Bonhoeffer P, De Groot NMS, et al. WSC guidelines for the management of grown-up congenital heart disease. Eur Heart J. 2010;31:2915–2957.
Dimopoulos K, Peset A, Gatzoulis MA. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy. Int J Cardiol. 2008;129(2):163–71.
Schwerzmann M, Zafar M, McLaughlin PR, et al. Atrial septal defect closure in a patient with “irreversible” pulmonary hypertensive arteriopathy. Int J Cardiol. 2006;110(1):104–7.
Benson LN, Child JS, Schwaiger M, Perloff JK, Schelbert HR. Left ventricular geometry and function in adults with Ebstein’s anomaly of the tricuspid valve. Circulation. 1987;75:353–9.
Carpentier A, Chauvaud S, Mace L, et al. A new reconstructive operation for Ebstein’s anomaly of the tricuspid valve. J Thorac Cardiovasc Surg. 1988;96(1):92–101.
Dearani JA, Danielson GK. Surgical management of Ebstein’s anomaly in the adult. Semin Thorac Cardiovasc Surg. 2005;17(2):148 – 54.
Hetzer R, Negdyman N, Ewert P, et al. A modified repair technique for tricuspid incompetence in Ebstein’s anomaly. J Thorac Cardiovasc Surg. 1998;115:857–68.
da Silva JP, Baumgratz JF, et al. The cone reconstruction of the tricuspid valve in Ebstein’s anomaly. The operation: early and midterm results. J Thorac Cardiovasc Surg. 2007;133:215–23.
Brown ML, Dearani JA, Danielson GK, et al. Comparison of the outcome of porcine bioprosthetic versus mechanical prosthetic replacement of the tricuspid valve in the Ebstein anomaly. Am J Cardiol. 2009;103(4):555 – 61.
Baudiu CC, Schriber C, et al. Early timing of surgical intervention in patients with Ebstein’s anomaly predicts superior long-term outcome. Eur J Cardiothorac Surg. 2010;37:186–92.
Brown ML, Dearani JA, et al. The outcomes of operations for 539 patients with Ebstein anomaly. J Thorac Cardiovasc Surg. 2008;135:1120–36.
Graham TP Jr, Bernard YD, Mellen BG, et al. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol. 2000;36(1):255 – 61.
Hraska V, Duncan BW, Mayer JE Jr, et al. Long-term outcome of surgically treated patients with corrected transposition of the great arteries. J Thorac Cardiovasc Surg. 2005;129(1):182 – 91.
Mongeon FP, Connolly HM, Derabi JA. Congenitally corrected transposition of the great arteries ventricular function at the time of systemic atrioventricular valve replacement predicts long-term ventricular function. J Am Coll Cardiol. 2011;57:2008–17.
Scherptong RW, Vliegen HW, Winter MM, et al. Tricuspid valve surgery in adults with a dysfunctional systemic right ventricle: repair or replace? Circulation. 2009;119(11):1467–72.
Ilbawi MN, DeLeon SY, Backer CL, et al. An alternative approach to the surgical management of physiologically corrected transposition with ventricular septal defect and pulmonary stenosis or atresia. J Thorac Cardiovasc Surg. 1990;100(3):410–5.
Duncan BW, Mee RB. Management of the failing systemic right ventricle. Semin Thorac Cardiovasc Surg. 2005;17(2):160–9.
Roubertie F, Peltan J, Henaine R, et al. Early to midterm results of total cavopulmonary connection in adult patients. Ann Thorac Surg. 2013;95(3):941–7.
Burkhart HM, Dearani JA, et al. The modified Fontan procedure: early and late results in 132 adult patients. J Thorac Cardiovasc Surg. 2003;125:1252–9.
Sughimoto K, Matsuo K, Niwa K, et al. Fontan completions over 10 years after Glenn procedures. Cardiol Young. 2014;24(2):290–6.
Oechslin E. Hematological management of the cyanotic adult with congenital heart disease. Int J Cardiol. 2004;97 Suppl 1:109 – 15.
Perrier S, Gerelli S, Hoang Minh T, Billaud P, et al. Concomitant repair of tetralogy of Fallot and an aortic root aneurysm in an adult. J Card Surg. 2017;32(1):57 – 9.
Erdogan HB, Bozbuga N, Kayalar N, Erentug V, Omeroglu SN, Kirali K, et al. Long-term outcome after total correction of tetralogy of Fallot in adolescent and adult age. J Card Surg. 2005;20(2):119–23.
Mizuno A, Niwa K, Matsuo K, et al. Survey of reoperation indications in tetralogy of fallot in Japan. Circ J. 2013;77(12):2942–7.
Gatzouli MA, Baraji S, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975–81.
Geva T. Indication and timing of pulmonary valve replacement after tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 11–22: 2006.
Therrien J, Provost Y, Merchant N, et al. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005;95:779–82.
Scherptong RW, Hazekamp MG, Mulder BJ, et al. Follow-up after pulmonary valve replacement in adults with tetralogy of Fallot: association between QRS duration and outcome. J Am Coll Cardiol. 2010;56:1486–92.
Hirose N, Matsuo K, Kabasawa M, et al. The mid-term effects of pulmonary valve replacement on right ventricular function in adult patients with tetralogy of Fallot. J Adult Congenit Heart Dis. 2013;2:22–8.
Burchill LJ, Wald RM, Harris L, Colman JM, Silversides CK. Pulmonary valve replacement in adults with repaired tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2011;14(1):92–7.
Sabate Rotes A, Eidem BW, Connolly HM, et al. Long-term follow-up after pulmonary valve replacement in repaired tetralogy of Fallot. Am J Cardiol. 2014;114(6):901–8.
Gelatt M, Hamilton RM, McCrindle BW, Gow RM, Williams WG, Trusler GA, et al. Risk factors for atrial tachyarrhythmias after the Fontan operation. J Am Coll Cardiol. 1994;24(7):1735–41.
Mavroudis C, Backer CL, Deal BJ, Johnsrude C, Strasburger J. Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation. J Thorac Cardiovasc Surg. 2001;122(5):863–71.
Backer CL. 12th Annual C. Walton Lillehei memorial lecture in cardiovascular surgery: Fontan conversion–the Chicago experience. Cardiol Young. 2011;21:169–76.
Hiramatsu T, Iwata Y, Matsumura G, Konuma T, Yamazaki K. Impact of Fontan conversion with arrhythmia surgery and pacemaker therapy. Eur J Cardiothorac Surg. 2011;40(4):1007–10.
Sridhar A, Giamberti A, Foresti S, Cappato R, Garcia CR, Cabrera ND, et al. Fontan conversion with concomitant arrhythmia surgery for the failing atriopulmonary connections: mid-term results from a single centre. Cardiol Young. 2011;21(6):665–9.
Brown ML, Dearani JA, Burkhart HM. The adult with congenital heart disease: medical and surgical considerations for management. Curr Opin Pediatr. 2009;21(5):561–4.
Srinathan SK, Bonser RS, Sethia B, Thorne SA, Brawn WJ, Barron DJ. Changing practice of cardiac surgery in adult patients with congenital heart disease. Heart. 2005;91(2):207–12.
Stellin G, Vida VL, Padalino MA, Rizzoli G, European Congenital Heart Surgeons A. Surgical outcome for congenital heart malformations in the adult age: a multicentric European study. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2004;7:95–101.
Vouhe P. Surgery for congenital heart disease in the adult: characteristics. Arch Mal Coeur Vaiss. 2002;95(11):1023–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matsuo, K., Kabasawa, M., Asano, S. et al. Surgical treatment for adult congenital heart disease: consideration for indications and procedures. Gen Thorac Cardiovasc Surg 66, 57–64 (2018). https://doi.org/10.1007/s11748-017-0861-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-017-0861-2